Thrombosis Research 1988-03-15

Effect of beta-pyridyl-carbinol on platelet aggregation.

J Manzanares, R Cantón, F Zaragoza

Index: Thromb. Res. 49(6) , 501-8, (1988)

Full Text: HTML

Abstract

We studied the anti-platelet aggregation activity of beta-pyridyl-carbinol (b-PC) (Ronicol, Roche). This compound has a chemical structure similar to nicotinic acid and is therapeutically indicated in functional and organic circulatory processes. We determined the in vitro antiaggregation activity induced by ADP (4 microM) and collagen (20 micrograms/ml) using Cardinal and Flower's technique. Antithrombotic activity was assessed in rats by measuring the duration of ADP-induced (12.40 micrograms/kg i.v.) respiratory dysfunction in 2 groups: one given 17.14 mg/kg beta-pyridyl-carbinol for 8 consecutive days before testing and controls. In vitro and in vivo results were highly significant. Circulating platelet count increased in b-PC treated animals. Systolic and diastolic pressures remained unmodified during administration of b-PC.

Related Compounds

  • Nicotinyl alcohol

Related Articles:

Inhibitory effects of niacin and its analogues on induction of ornithine decarboxylase activity by diethylnitrosamine in rat liver.

1987-09-15

[Biochem. Pharmacol. 36(18) , 3015-9, (1987)]

The role of p53 in the cellular toxicity by active trans-platinum complexes containing isopropylamine and hydroxymethylpyridine.

2010-01-01

[Eur. J. Med. Chem. 45(1) , 134-41, (2010)]

Oxidation of alcohols using a manganese (II) complex based on a pentakis benzimidazole amide ligand.

2009-10-01

[Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 74(2) , 536-43, (2009)]

Enzymatic oxidation of NADP+ to its 4-oxo derivative is a side-reaction displayed only by the adrenodoxin reductase type of ferredoxin-NADP+ reductases.

2007-08-01

[FEBS J. 274(15) , 3998-4007, (2007)]

Unusual but reversible hepatic lesions following long-term treatment with pyridylcarbinol for familial hypercholesterolemia.

1988-07-15

[Klin. Wochenschr. 66(14) , 647-50, (1988)]

More Articles...